Retinal vein occlusion (RVO) is a major cause of visual loss. Plasma Homocysteine and Cysteine Levels in Retinal Vein Occlusion
|
|
- Ellen Reed
- 6 years ago
- Views:
Transcription
1 Plasma Homocysteine and Cysteine Levels in Retinal Vein Occlusion Antonio Pinna, 1 Ciriaco Carru, 2 Angelo Zinellu, 2 Stefano Dore, 1 Luca Deiana, 2 and Francesco Carta 1 PURPOSE. To determine plasma homocysteine and cysteine levels in patients with retinal vein occlusion (RVO) and in healthy subjects and to ascertain whether there are statistically significant differences between patients and control subjects. METHODS. In this case control study, the study group consisted of 75 consecutive patients with RVO: 33 had central retinal vein occlusion (CRVO), and 42 had branch retinal vein occlusion (BRVO). Seventy-two apparently healthy age- and sexmatched subjects served as control subjects. Homocysteine and cysteine levels were measured with a new laser-induced fluorescence capillary electrophoresis (CE-LIF) method. Wilcoxon or Student s t-test was used, when appropriate, to determine differences between groups. RESULTS. There were no significant differences in median plasma homocysteine between patients with RVO and control subjects, nor were there any statistically significant differences when patients were categorized by type of vein occlusion (CRVO or BRVO). Similarly, there were no significant differences in mean plasma cysteine between patients with RVO and control subjects. However, when categorized by type of vein occlusion, mean plasma cysteine was significantly higher in CRVO patients than in control subjects (P 0.034). CONCLUSIONS. This study failed to demonstrate an association between increased plasma homocysteine and RVO. Mean plasma cysteine was significantly higher in patients with CRVO, suggesting that hypercysteinemia may contribute to the pathogenesis of this retinal vascular disorder. (Invest Ophthalmol Vis Sci. 2006;47: ) DOI: /iovs Retinal vein occlusion (RVO) is a major cause of visual loss. This condition can involve the central trunk or branches of the retinal venous circulation (CRVO and BRVO, respectively). Elevated plasma homocysteine, which is associated with venous thrombosis and cardiovascular disease, 1,2 has been suggested as an important potentially modifiable risk factor for RVO In contrast, little is known about the role played by plasma cysteine in RVO. Elevated plasma cysteine has recently been suggested to be a cardiovascular risk factor. 15,16 Although less reactive than homocysteine, cysteine shares some of the chemical properties, due to the presence of its sulfhydryl group in the molecule. Cysteine has a general cytotoxicity in vitro and promotes detachment of human arterial endothelial cells in culture. It also exhibits auto-oxidation properties in the From the 1 Institute of Ophthalmology and the 2 Department of Biochemistry, University of Sassari, Sassari, Italy. Submitted for publication March 17, 2006; revised May 12 and 23, 2006; accepted July 21, Disclosure: A. Pinna, None; C. Carru, None; A. Zinellu, None; S. Dore, None; L. Deiana, None; F. Carta, None The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked advertisement in accordance with 18 U.S.C solely to indicate this fact. Corresponding author: Antonio Pinna, Institute of Ophthalmology, University of Sassari, Viale San Pietro 43 A, Sassari, Italy; apinna@uniss.it. presence of metal ions, resulting in the generation of free radicals and hydrogen peroxide. The purpose of this study was to determine plasma homocysteine and cysteine levels in patients with RVO and apparently healthy subjects and to ascertain whether there are statistically significant differences between patients and control subjects. METHODS The present study had a case control design, recruiting 75 consecutive patients with RVO (CRVO or BRVO) admitted to our institute between April 2003 and November The duration of visual symptoms, ocular medication, and ocular history were noted. A full ophthalmic evaluation of both eyes was performed, including best corrected visual acuity (BCVA), slit lamp examination, applanation tonometry, fundus biomicroscopy, and fluorescein angiography. Medical conditions, including diabetes, systemic hypertension, cardiovascular status, decreased renal function, relevant drug history, and presence of blood dyscrasias were also recorded. Exclusion criteria included age 18 years, renal failure, and current medication with vitamin B6, B12, or folic acid. Similar to other studies analyzing the relationship between plasma homocysteine and cysteine levels and vascular occlusive disease, we chose a control group of apparently healthy subjects. 16 The control group included 72 subjects, recruited from accompanying relatives or friends of patients or from hospital personnel. Exclusion criteria for control subjects were a history of diabetes, systemic hypertension, cardiovascular or cerebrovascular disease, renal failure, blood dyscrasias, tumors, retinal vascular disorders, age 18 years, and current medication with vitamin B6, B12, or folic acid. All control subjects underwent standard ophthalmic evaluation, including BCVA, slit lamp examination, applanation tonometry, and fundus examination. Control subjects were recruited concurrently during the patients recruitment period. A blood sample was taken from each participant after an overnight fast. Blood for homocysteine and cysteine was collected in an EDTA tube, transported on ice, and immediately centrifuged at 3000g for 10 minutes at 4 C, for plasma and serum separation. Then, the samples were stored at 80 C and analyzed within 1 week. Total plasma thiols were measured by capillary electrophoresis laserinduced detection (P/ACE; Beckman Instruments, Fullerton, CA), as described previously. 17 Briefly, 100 L of standard or plasma sample was mixed with 10 L of tributylphosphine (10%; TBP), vortexed for 30, seconds and subsequently incubated at 4 C for 10 minutes. After incubation, 100 L of trichloracetic acid (10%; TCA) was added, vortexed for 10 seconds, and then centrifuged at 3000g for 10 minutes; 100 L of supernatant was mixed with 100 L of 300 mm Na 3 PO 4 (ph 12.5) and 25 L of 5-IAF (4.1 mm), incubated at room temperature for 10 minutes, and finally injected in capillary electrophoresis. Analysis of plasma thiols was performed by a masked individual (AZ). In addition, serum vitamin B12 and folate levels were measured in all patients with RVO (IMX Analyzer; Abbott Laboratories Diagnostics Division, Abbott Park, IL). The IMX B12 assay is based on the microparticle enzyme immunoassay (MEIA) technology, whereas the IMX folate assay is an ion-capture assay technique. For these immunologic assays, inter- and intra-assay coefficients of variation were 10%. Nor- Investigative Ophthalmology & Visual Science, September 2006, Vol. 47, No. 9 Copyright Association for Research in Vision and Ophthalmology 4067
2 4068 Pinna et al. IOVS, September 2006, Vol. 47, No. 9 TABLE 1. Characteristics of Patients with CRVO or BRVO mal values for plasma vitamin B12 and folate are 179 to 1162 pg/ml and 2.7 to 34 ng/ml, respectively. Institutional ethics review board approval was obtained, and the study was conducted in full accord with the tenets of the Declaration of Helsinki. Each participant received detailed information and provided informed consent before inclusion. Analysis of normality for homocysteine and cysteine distribution was performed using the Kolmogorov-Smirnov test. Wilcoxon or Student s t-test was used, when appropriate, to calculate differences between patients with RVO and control subjects. P 0.05 was considered to be statistically significant (StatGraphics ver. 5.0 for Windows; StatPoint Inc., Herndon, VA). RESULTS CRVO (n 33) BRVO (n 42) Sex Male 19 (58%) 21 (50%) Female 14 (42%) 21 (50%) Age (y, mean SD) Diabetes Yes 4 (12%) 3 (7%) No 29 (88%) 39 (93%) Hypertension Yes 15 (45%) 18 (43%) No 18 (55%) 24 (57%) Hypercholesterolemia ( 220 mg/dl) Yes 17 (52%) 24 (57%) No 16 (48%) 18 (43%) Cardiovascular history No 25 (76%) 37 (88%) Angina/myocardial infarction 8 (24%) 5 (12%) Thrombosis/embolism Yes 1 (3%) 0 No 32 (97%) 42 (100%) Anticoagulant medication Yes 8 (24%) 8 (19%) No 25 (76%) 34 (81%) Unless otherwise stated, data are the number of subjects (percentage of group). The study cohort consisted of 75 patients with RVO (40 men, 35 women; mean age: years; 95% CI: ). Thirty-three patients (19 men, 14 women; mean age: years, 95% CI: ) had CRVO and 42 (21 men, 21 women; mean age: years, 95% CI: ) had BRVO. The patients characteristics are reported in Table 1. All patients had similar rates of diabetes, hypertension, hypercholesterolemia, and anticoagulant use, but patients with CRVO had twice the incidence of positive cardiovascular history (angina/myocardial infarction) when compared with those with BRVO; however, this result did not reach statistical significance (P 0.16). The control group consisted of 72 subjects (37 men, 35 women; mean age: years, 95% CI: ); none had signs of retinal vascular disorders. Patients and control subjects were well matched for age (RVO patients versus control subjects: P 0.89, CRVO patients versus control subjects: P 0.91, BRVO patients versus control subjects: P 0.72) and sex (RVO patients versus control subjects: P 0.82, CRVO patients versus control subjects: P 0.7, BRVO patients versus control subjects: P 0.93). Homocysteine levels showed a non-normal distribution; accordingly, statistical analysis was performed with the Wilcoxon TABLE 2. Plasma Homocysteine Concentration test. This result, due to the positively skewed distribution of homocysteine in both patients and control subjects, is consistent with the literature. 18,19 There were no significant differences in median plasma homocysteine between patients with RVO and control subjects (Table 2), nor were there any statistically significant differences when patients were categorized by type of vein occlusion (CRVO or BRVO). Cysteine values showed a normal distribution; as a result, statistical analysis was performed using the Student s t-test. There were no significant differences in mean plasma cysteine between patients with RVO and control subjects (Table 3). However, when categorized by type of vein occlusion, mean plasma cysteine was significantly higher in patients with CRVO than in control subjects (P 0.034). Mean plasma vitamin B12 and folate values in patients with RVO, CRVO, or BRVO are shown in Table 4. DISCUSSION Concentration RVO patients (n 75) ( ) 0.24 CRVO patients (n 33) 10.7 ( ) 0.99 BRVO patients (n 42) 9.85 ( ) 0.07 Control subjects (n 72) 10.8 ( ) Data are expressed as median micromoles per liter (range). Patients were compared to control subjects with the Wilcoxon test. Homocysteine is a potentially cytotoxic sulfur-containing amino acid produced during the metabolism of the essential amino acid methionine (Fig. 1). Methionine, which comes from dietary animal protein, donates methyl groups to vital transmethylation reactions, which produce important molecules such as creatine and phosphatidylcholine, and allows methylation of DNA, RNA, and neurotransmitters. 20 Homocysteine is an essential intermediate in the transfer of activated methyl groups from tetrahydrofolate to S-adenosylmethionine in the remethylation pathway. It is also an intermediate in the pathway of synthesis of cysteine from methionine (transsulfuration pathway). In the remethylation pathway, homocysteine is remethylated to methionine by transfer of a methyl group from N-5-methyltetrahydrofolate, catalyzed by methionine synthase, an enzyme that requires vitamin B12 as a cofactor. In the transsulfuration pathway, homocysteine is the substrate of the vitamin B6-dependent enzyme cystathionine -synthase, which catalyzes its condensation with serine to form cystathionine. This is the critical step in the pathway because it is irreversible under physiological conditions. From this point on, homocysteine is committed to follow this pathway. In the last step of the transsulfuration pathway, cystathionine is cleaved by -cystathionase, another vitamin B6-dependent enzyme, to form 2-oxoglutarate and cysteine. There is still no general agreement on the role of hyperhomocysteinemia in RVO. Eleven case control studies, one pop- TABLE 3. Plasma Cysteine Concentration Concentration 95% CI P RVO patients (n 75) CRVO patients (n 33) BRVO patients (n 42) Control subjects (n 72) Data are mean micromoles per liter SD. Patients were compared to control subjects with Student s t-test. P
3 IOVS, September 2006, Vol. 47, No. 9 Homocysteine and Cysteine in Retinal Vein Occlusion 4069 TABLE 4. Plasma Vitamin B12 and Folate Concentrations Arithmetic Mean SD 95% CI Vitamin B12 (pg/ml) RVO patients (n 75) CRVO patients (n 33) BRVO patients (n 42) Folate (ng/ml) RVO patients (n 75) CRVO patients (n 33) BRVO patients (n 42) Normal plasma vitamin B12 concentrations: pg/ml. Normal plasma folate concentrations: ng/ml. ulation-based study, and one meta-analysis have shown plasma homocysteine to be significantly higher in patients than in control subjects Conversely, five other case control studies failed to demonstrate an association. 18,20 24 Ophthalmic patients without RVO were used as control subjects in five studies, 5,9,10,12,23 whereas a mixture of hospital staff and ophthalmic patients without RVO was used in three studies. 3,4,18 Other control groups included the general population, 13 apparently healthy adults, 6,7,14,23 blood donors, 8,21 or individuals matched for age, gender, laboratory, and the main risk factors for atherosclerosis. 24 The use of different criteria for the selection of control subjects may in part explain the contrasting results reported in the literature. In addition, a small number of patients were analyzed in several studies (20 RVO, 7 33 RVO, 12 and 21 CRVO, 22 ), which may limit the validity of the results. Age is an important confounding factor when analyzing the potential role of plasma homocysteine in vascular disorders. In a large, apparently healthy population (n 11,941), increasing age was shown to correlate with elevated homocysteine. 25 Although many of the studies in the literature state that patients and control subjects were age-matched, the precision of matching and a statistical test of the outcome of matching are rarely presented. It is noteworthy that in two of the studies identifying homocysteine as a risk factor for RVO, the control subjects were not fully age-matched and that in another report they were significantly younger than the patients (P ). 4 6 In these studies, the use of control subjects who were on average 3 years, 4 5 years, 6 and 14 years 6 younger than the patients could account for the finding of significant differences. In contrast, in one report that failed to demonstrate an association between increased homocysteine and CRVO, the patients were significantly younger than the control subjects (P 0.005). 22 Another potential source of bias is the patient s condition (fasting or nonfasting state) at the time blood samples were collected. It is generally recommended that subjects be in the fasting state when homocysteine is measured. 26 In a case control study showing an association between hyperhomocysteinemia and CRVO, nonfasting blood samples were obtained from both patients and control subjects. 5 In a similar study reporting elevated homocysteine levels in patients with RVO, nonfasting blood samples from patients and fasting samples from blood donors were analyzed. 8 The procedures used in these studies may have led to the finding of higher homocysteine levels in the patients than in the control subjects. Decreased renal function with reduced clearance of homocysteine results in elevated plasma homocysteine levels, which are inversely related to serum creatinine levels. 11 In two studies showing an association between hyperhomocysteinemia and RVO, the patients renal function was not investigated. 8,14 As a result, we cannot rule out the possibility of a moderately decreased glomerular filtration rate as a mechanism responsible for the increased homocysteine levels observed. Although the control subjects in our study were similar to the patients in age and sex distribution, we did not match for other factors potentially capable of altering homocysteine levels, such as tobacco smoking and excessive alcohol intake, which, however, do not affect cysteinemia. 11,16 Another potential limitation of this study is that we did not assess the 5,10-methylenetetrahydrofolate reductase (MTHFR) genotype. Subjects homozygous for the thermolabile variant of MTHFR show higher plasma levels of homocysteine, particularly when serum folate levels are low. However, most studies on MTHFR FIGURE 1. Path of homocysteine and cysteine metabolism. Methionine from dietary animal protein donates methyl groups to vital transmethylation reactions, producing important molecules such as creatine and phosphatidylcholine, and allows methylation of DNA, RNA, and neurotransmitters.
4 4070 Pinna et al. IOVS, September 2006, Vol. 47, No. 9 genotype failed to identify the presence of the thermolabile polymorphism as a risk factor for RVO. 9,10,18,21,23,24 Our study showed that patients with RVO and control subjects had similar plasma homocysteine concentrations, a result consistent with that reported in other studies. 18,21 24 We also found no significant differences in mean plasma cysteine between patients with RVO and control subjects. However, when categorized by type of vein occlusion, mean plasma cysteine was significantly higher in patients with CRVO than in control subjects. This result may be explained in part by the patient s nutritional status. Although CRVO and BRVO patients had similar plasma vitamin B12 and folate levels, we found that patients with CRVO had a lower mean concentration ( 17.3%) of folate than did patients with BRVO. As folate is essential for the conversion of homocysteine to methionine in the remethylation pathway, the reduced intake of folate in patients with CRVO may be responsible for homocysteine s being directed predominantly toward the transsulfuration pathway, thus leading to an increased level of plasma cysteine. Our results are in agreement with a recent study on the relationship between plasma cysteine levels and the risks of vascular disease, which found that hypercysteinemia is associated with decreased plasma folate. 16 In contrast, no relationship was found between hypercysteinemia and vitamin B We are unaware of any previously reported study assessing plasma cysteine levels in patients with RVO. The concentration of total cysteine in serum and plasma from healthy subjects is 200 to 230 M, which is 20 times higher than the plasma homocysteine level. 27 Cysteine shares some of homocysteine s chemical properties derived from the presence of its sulfhydryl group. 28 It is cytotoxic in vitro and promotes the detachment of human arterial endothelial cells in culture. 29,30 Cysteine also exhibits auto-oxidation properties in the presence of metal ions, 31 resulting in the generation of free radicals and hydrogen peroxide, which promote the activation of the cellular immune system and support superoxide-mediated modification of lowdensity lipoprotein (LDL). 32,33 Therefore, auto-oxidation of cysteine in vitro promotes several processes involved in atherogenesis and thrombogenesis The in vivo effects of hypercysteinemia on vascular endothelium may be more relevant than those of hyperhomocysteinemia, because of its higher concentration. Previous studies have demonstrated increased cysteine levels in patients with myocardial infarction, 38 cerebral infarction, 39 or peripheral vascular disease. 40 In addition, recent studies have shown that increased plasma cysteine is a cardiovascular risk factor. 15,16 The detection of significantly higher levels of plasma cysteine in patients with CRVO raises the interesting question of whether hypercysteinemia, apart from being a cardiovascular risk factor, also plays a role in the pathogenesis of CRVO. It is noteworthy that, in our study, one fourth of the patients with CRVO had a positive cardiovascular history, twice the incidence when compared with BRVO patients. The increased levels of plasma cysteine, observed only in the CRVO group, may account for this result. In conclusion, this study failed to demonstrate an association between increased plasma homocysteine and RVO. Mean plasma cysteine was significantly higher in CRVO patients, thus suggesting that hypercysteinemia may contribute to the pathogenesis of this retinal vascular disorder. Larger studies are needed to confirm our results and elucidate the possible mechanisms by which increased plasma cysteine may cause CRVO. References 1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274: Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338: Cahill M, Karabatzaki M, Meleady R, et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol. 2000;84: Martin SC, Rauz S, Marr JE, Martin N, Jones AF, Dodson PM. Plasma total homocysteine and retinal vascular disease. Eye. 2000;14: Vine AK. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion. Trans Am Ophthalmol Soc. 2000;98: Marcucci R, Bertini L, Giusti B, et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemostasis. 2001;86: Brown BA, Marx JL, Ward PT, et al. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology. 2002;109: Abu El-Asrar AM, Abdel Gader AG, Al-Amro SA, Al-Attas OS. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol. 2002;12: Weger M, Stanger O, Deutschmann H, et al. Hyperhomocysteinemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2002;240: Weger M, Stanger O, Deutschmann H, et al. Hyperhomocysteinemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology. 2002;109: Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol. 2003;136: Yildirim C, Yaylali V, Tatlipinar S, Kaptanoglu B, Akpinar S. Hyperhomocysteinemia: a risk factor for retinal vein occlusion. Ophthalmologica. 2004;218: Chua B, Kifley A, Wong TY, Mitchell P. Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol. 2005; 139: Lattanzio R, Sampietro F, Ramoni A, Fattorini A, Brancato R, D Angelo A. Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion. Retina. 2006;26: Jacob N, Bruckert E, Giral P, et al. Cysteine is a cardiovascular risk factor in hyperlipidemic patients. Atherosclerosis. 1999;146: El-Khairy L, Ueland PM, Refsum H, et al. Plasma total cysteine as a risk factor for vascular disease. Circulation. 2001;103: Zinellu A, Carru C, Galistu F, et al. N-methyl-D-glucamine improves the laser-induced fluorescence capillary electrophoresis performance in the total plasma thiols measurement. Electrophoresis. 2003;24: McGimpsey SJ, Woodside JV, Bamford L, et al. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype. Invest Ophthalmol Vis Sci. 2005;46: Rodriguez JJ, Santolaria F, Martinez-Riera A, et al. Clinical significance of homocysteine in elderly hospitalized patients. Metabolism. 2006;55: Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1: Larsson J, Hultberg B, Hillarp A. Hyperhomocysteinemia and the MTHFR C677T mutation in central vein occlusion. Acta Ophthalmol Scand. 2000;78: Pianka P, Almog Y, Man O, Goldstein M, Sela BA, Loewenstein A. Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107: Boyd S, Owens D, Gin T, et al. Plasma homocysteine, methylenetetrahydrofolate reductase C677T and factor II G20210A polymorphism, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol. 2001;85: Di Crecchio L, Battaglia Parodi M, Sanguinetti G, Iacono P, Ravalico G. Hyperhomocysteinemia, and the methylenetetrahydrofolate reductase C677T mutation in patients under 50 years of age affected by central retinal vein occlusion. Ophthalmology. 2004;111:
5 IOVS, September 2006, Vol. 47, No. 9 Homocysteine and Cysteine in Retinal Vein Occlusion Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr. 1998;67: Refsum H, Fiskerstrand T, Guttormsen AB, Ueland PM. Assessment of homocysteine status. J Inherit Metab Dis. 1997;20: Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem. 1995;41: Stamler JS, Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev. 1996;54: Nishiuch Y, Sasaki M, Nakayasu M, et al. Cytotoxicity of cysteine in culture media. In Vitro. 1976;12: Dudman NP, Hicks C, Wang J, et al. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis. 1991;91: Saez G, Thornalley PJ, Hill HA, et al. The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes. Biochim Biophys Acta. 1982;719: Lakshminarayanan V, Lewallen M, Frangogiannis NG, et al. Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. Am J Pathol. 2001; 159: Heinecke JW, Rosen H, Suzuki LA, et al. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem. 1987;262: Hogg N. The effect of cysteine on the auto-oxidation of homocysteine. Free Radic Biol Med. 1999;27: Welch GN, Upchurch GR, Loscalzo J. Homocysteine, oxidative stress, and vascular disease. Hosp Pract. 1997;32: Starkebaum G, Harlan JM. Endothelial cell injury due to coppercatalyzed endothelial cell injury from homocysteine. J Clin Invest. 1986;77: Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 1994;91: Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 1996;143: Araki A, Sako Y, Fukushima Y, et al. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis. 1989;79: Mansoor MA, Bergmark C, Svardal AM, et al. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol. 1995;15:
PREVALENCE OF HYPERHOMOCYSTEINEMIA IN PATIENTS WITH RETINAL VEIN OCCLUSION
PREVALENCE OF HYPERHOMOCYSTEINEMIA IN PATIENTS WITH RETINAL VEIN OCCLUSION M. R. Manaviat *, M. R. Shoja and M. R. Besharaty Department of Ophthalmology, School of Medicine, Yazd University of Medical
More informationPredictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study
Clinical Chemistry 49:1 113 120 (2003) Lipids, Lipoproteins, and Cardiovascular Risk Factors Predictors of Change in Plasma Total Cysteine: Longitudinal Findings from the Hordaland Homocysteine Study Lina
More informationCorrespondence should be addressed to: Jelena Paovic; Received date: 23 April 2014; Accepted date: 7 July 2014; Published date: 8 June 2015
IBIMA Publishing Research in Immunology: An International Journal http://www.ibimapublishing.com/journals/immu/immu.html Vol. 2015 (2015), Article ID 246396, 11 pages DOI: 10.5171/2015.246396 Research
More informationImpairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy
Clin Chem Lab Med 2005;43(10):1020 1025 2005 by Walter de Gruyter Berlin New York. DOI 10.1515/CCLM.2005.179 2005/230 Impairment of homocysteine metabolism in patients with retinal vascular occlusion and
More informationHyperhomocysteinemia is a major and independent risk
Clinical Research Investigation of Relationship Between Reduced, Oxidized, and Protein-Bound Homocysteine and Vascular Endothelial Function in Healthy Human Subjects John C. Chambers, Per M. Ueland, Melissa
More informationHigh Blood Pressure in Irish Adults
High Blood Pressure in Irish Adults Preliminary findings and lessons learned from two JINGO cohorts Helene McNulty Northern Ireland Centre for Food and Health (NICHE) University of Ulster Mortality due
More informationMetabolism of. Sulfur Containing Amino Acids
Metabolism of Sulfur Containing Amino Acids Methionine S CH 3 CH 2 cysteine CH 2 SH CH 2 CHNH 2 COOH CHNH 2 COOH Essential amino acid Non-polar amio acid Glucogenic amino acid Methionine IMPORTANCE: As
More informationHyperhomocysteinaemia A Risk Factor Worth Considering
REVIEW ARTICLE JIACM 2003; 4(2): 147-51 Hyperhomocysteinaemia A Risk Factor Worth Considering Pramood C Kalikiri* At least nine well-known risk factors are known to play a role in the development of coronary
More informationAssociation between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease
Association between Plasma Homocysteine Concentrations and Carotid Intima-Media Thickness in Patients with Coronary Artery Disease ROXANA BUZAŞ, CORINA ŞERBAN, IOANA SUCEAVA, DANIEL LIGHEZAN University
More informationCase Report: Indocyanine Green Dye Leakage from Retinal Artery in Branch Retinal Vein Occlusion
Case Report: Indocyanine Green Dye Leakage from Retinal Artery in Branch Retinal Vein Occlusion Hiroki Fujita, Kyoko Ohno-Matsui, Soh Futagami and Takashi Tokoro Department of Visual Science, Tokyo Medical
More informationNitrous Oxide induced Elevation of Plasma Homocysteine and Methylmalonic Acid Levels and their Clinical Implications
SHORT COMMUNICATION JIACM 2005; 6(1): 48-52 Abstract Nitrous Oxide induced Elevation of Plasma Homocysteine and Methylmalonic Acid Levels and their Clinical Implications Pramood C Kalikiri*, Reena G Sachan*
More informationin a population with low plasma
518 Cardiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey S L Tokgözoğlu E Atalar K Aytemir N Özer K Övünç S Kes Paediatric Genetics, Hacettepe University Faculty of Medicine M Alikaşifoğlu
More informationHOMOCYSTEINE AND CARDIOVASCULAR DISEASE
Annu. Rev. Medicine 1998. 49:31 62 Copyright 1998 by Annual Reviews Inc. All rights reserved HOMOCYSTEINE AND CARDIOVASCULAR DISEASE H. Refsum, MD and P. M. Ueland, MD Department of Pharmacology, University
More informationOcular Manifestations of Hyperhomocysteinemia and their Response to Therapeutic Modalities
Original Article DOI: 10.17354/ijss/2015/269 Ocular Manifestations of Hyperhomocysteinemia and their Response to Therapeutic Modalities H N Sowbhagya 1, Minal Kothari 2, L Kiran Kumar 3, Nivedhitha Nikhil
More informationCBS Deficient Homocystinuria.
CBS Deficient Homocystinuria. Kenneth N. Maclean PhD University of Colorado School of Medicine Department of Pediatrics The methionine cycle Alternative metabolic fates for Hcy Extrusion into the extracellular
More informationHyperhomocysteinemia is an independent risk factor for. Improved Vascular Endothelial Function After Oral B Vitamins
Improved Vascular Endothelial Function After Oral B Vitamins An Effect Mediated Through Reduced Concentrations of Free Plasma Homocysteine John C. Chambers, MD; Per M. Ueland, MD; Omar A. Obeid, PhD; Jane
More informationClinical Policy: Homocysteine Testing Reference Number: CP.MP.121
Clinical Policy: Reference Number: CP.MP.121 Effective Date: 08/16 Last Review Date: 08/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationNitrous Oxide Induced Elevation Of Plasma Homocysteine And Methylmalonic Acid Levels And Their Clinical Implications
ISPUB.COM The Internet Journal of Anesthesiology Volume 8 Number 2 Nitrous Oxide Induced Elevation Of Plasma Homocysteine And Methylmalonic Acid Levels And Their Clinical Implications P Kalikiri, R Sachan
More informationDR as a Biomarker for Systemic Vascular Complications
DR as a Biomarker for Systemic Vascular Complications Lihteh Wu MD Asociados de Mácula, Vítreo y Retina de Costa Rica San José, Costa Rica LW65@cornell.edu Disclosures Dr Wu has received lecture fees from
More informationBiochemistry: A Short Course
Tymoczko Berg Stryer Biochemistry: A Short Course Second Edition CHAPTER 31 Amino Acid Synthesis 2013 W. H. Freeman and Company Chapter 31 Outline Although the atmosphere is approximately 80% nitrogen,
More informationCase Report Hyperbaric Oxygen Therapy in Branch Retinal Artery Occlusion in a 15-Year-Old Boy with Methylenetetrahydrofolate Reductase Mutation
Case Reports in Ophthalmological Medicine Volume 2015, Article ID 640247, 4 pages http://dx.doi.org/10.1155/2015/640247 Case Report Hyperbaric Oxygen Therapy in Branch Retinal Artery Occlusion in a 15-Year-Old
More informationNeovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion
Neovascular Glaucoma Associated with Cilioretinal Artery Occlusion Combined with Perfused Central Retinal Vein Occlusion Man-Seong Seo,* Jae-Moon Woo* and Jeong-Jin Seo *Department of Ophthalmology, Chonnam
More informationDiabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion
European Journal of Ophthalmology / Vol. 13 no. 7, 2003 / pp. 648-652 Diabetes mellitus: A risk factor affecting visual outcome in branch retinal vein occlusion J. SWART 1,2, J.W. REICHERT-THOEN 1, M.S.
More informationHyperhomocysteinemia is known to be an. Methylenetetrahydrofolate Reductase Gene Polymorphism. Relation to Blood Pressure and Cerebrovascular Disease
AJH 1998;11:1019 1023 BRIEF COMMUNICATIONS Methylenetetrahydrofolate Reductase Gene Polymorphism Relation to Blood Pressure and Cerebrovascular Disease Yukiko Nakata, Tomohiro Katsuya, Seiju Takami, Noriyuki
More informationDR NAGY VALÉRIA RETINAL VASCULAR DISEASES: THE RARE FORMS OF THROMBOPHILIA.
DR NAGY VALÉRIA RETINAL VASCULAR DISEASES: THE RARE FORMS OF THROMBOPHILIA. UNIVERSITY OF DEBRECEN MEDICAL AND HEALTH SCIENCE CENTRE FACULTY OF MEDICINE Department of Ophthalmology and Division of Rare
More informationRelationship of Total Homocysteine, Cholesterol, Triglyceride in the Serum and Diastolic Blood Pressure of Patients with Myocardial Infarction
Relationship of Total Homocysteine, Cholesterol, Triglyceride in the Serum and Diastolic Blood Pressure of Patients with Myocardial Infarction Durdi Qujeq *1, Laia Hossini 1 and M. Taghi Salehi Omran 2
More informationEffect of Folic Acid on Serum Homocysteine Levels in Patients with Cardiovascular Diseases (CVD)
Human Journals Research Article August 2015 Vol.:4, Issue:1 All rights are reserved by Narmatha.M.P et al. Effect of Folic Acid on Serum Homocysteine Levels in Patients with Cardiovascular Diseases (CVD)
More informationNeuropathy (NAION) and Avastin. Clinical Assembly of the AOCOO-HNS Foundation May 9, 2013
Non Arteritic Ischemic Optic Neuropathy (NAION) and Avastin Shalom Kelman, MD Clinical Assembly of the AOCOO-HNS Foundation May 9, 2013 Anterior Ischemic Optic Neuropathy Acute, painless, visual loss,
More informationHOMOCYSTEINE (H(e)) is a nonprotein-forming, thiolcontaining
0163-769X/99/$03.00/0 Endocrine Reviews 20(5): 738 759 Copyright 1999 by The Endocrine Society Printed in U.S.A. Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis
More informationDeterminants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia ( 40 mol/liter)
Determinants and Vitamin Responsiveness of Intermediate Hyperhomocysteinemia ( 40 mol/liter) The Hordaland Homocysteine Study Anne Berit Guttormsen,* Per Magne Ueland,* Ingerid Nesthus, Ottar Nygård, Jörn
More informationIndependent Risk Factors of Cardiovascular Disease Achieving Healthy Homocysteine Levels
Independent Risk Factors of Cardiovascular Disease Achieving Healthy Homocysteine Levels AUTHORS: JON LEGERE, BRADLEY RALPH, DR. RON LEGERE 15344 N 83RD WAY, SCOTTSDALE, AZ 85260 TEL: 800.528.3144 EMAIL:
More informationHomocysteine Determination in Plasma
omocysteine Determination in Plasma Bruce Peary Solomon, Ph.D. Chester T. Duda, Ph.D. Bioanalytical Systems, Inc. West Lafayette, IN E-mail: bp@bioanalytical.com Recent publications suggest that high homocysteine
More informationPrevalence of Hyperhomocysteinemia in Patients with Predialysis Chronic Kidney Disease after Folic Acid Food Fortification of the Canadian Food Supply
Prevalence of Hyperhomocysteinemia in Patients with Predialysis Chronic Kidney Disease after Folic Acid Food Fortification of the Canadian Food Supply by Linda Jane Paterson A thesis submitted in conformity
More informationOne third to one half of the variation in vascular disease
Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease Jeffrey L. Anderson, MD; Joseph
More informationΟ ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη
Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη Κωνσταντίνος Τζιόμαλος Επίκουρος Καθηγητής Παθολογίας Α Προπαιδευτική Παθολογική Κλινική, Νοσοκομείο
More informationHYPERHOMOCYSTEINEMIA: RELATION TO CARDIOVASCULAR DISEASE (PDF) HOMOCYSTEINE AND RELATED B-VITAMIN STATUS IN COELIAC
PDF HYPERHOMOCYSTEINEMIA: RELATION TO CARDIOVASCULAR DISEASE (PDF) HOMOCYSTEINE AND RELATED B-VITAMIN STATUS IN COELIAC 1 / 5 2 / 5 3 / 5 homocysteine related vitamins pdf Hyperhomocysteinemia: Relation
More informationReview Article. Mechanisms of Disease
Review Article Mechanisms of Disease F RANKLIN H. EPSTEIN, M.D., Editor HMCYSTEINE AND ATHERTHRMBSIS GERGE N. WELCH, M.D., AND JSEPH LSCALZ, M.D., PH.D. IN 1969, McCully made the clinical observation linking
More informationPlasma homocysteine concentrations in a Belgian school-age population 1 3
Plasma homocysteine concentrations in a Belgian school-age population 1 3 Corinne De Laet, Jean-Claude Wautrecht, Daniel Brasseur, Michèle Dramaix, Jean-Marie Boeynaems, Jean Decuyper, and André Kahn ABSTRACT
More informationOptical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
Columbia International Publishing Journal of Ophthalmic Research (2014) Research Article Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
More informationFolate/folic acid and interactions with other B vitamins This talk will cover
Scientific update on B vitamins: Folate/folic acid and interactions with other B vitamins Helene McNulty Northern Ireland Centre for Food and Health (NICHE) University of Ulster Folate/folic acid and interactions
More informationREVIEW ARTICLE. Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease
Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease Causal or Casual? REVIEW ARTICLE William G. Christen, ScD; Umed A. Ajani, MBBS; Robert J. Glynn, ScD; Charles H. Hennekens, MD
More informationHOMOCYSTEINE METABOLISM
Annu. Rev. Nutr. 1999. 19:217 46 Copyright c 1999 by Annual Reviews. All rights reserved HOMOCYSTEINE METABOLISM J. Selhub Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston,
More informationRETINAL VEIN OCCLUSION
EPIDEMIOLOGY Retinal Vein Occlusion and Traditional Risk Factors for Atherosclerosis Paul R. A. O Mahoney; David T. Wong, MD, FRCSC; Joel G. Ray, MD, MSc, FRCPC Objective: To determine whether retinal
More informationOCCLUSIVE VASCULAR DISORDERS OF THE RETINA
OCCLUSIVE VASCULAR DISORDERS OF THE RETINA Learning outcomes By the end of this lecture the students would be able to Classify occlusive vascular disorders (OVD) of the retina. Correlate the clinical features
More informationThrombosis. By Dr. Sara Mohamed Abuelgasim
Thrombosis By Dr. Sara Mohamed Abuelgasim 1 Thrombosis Unchecked, blood coagulation would lead to dangerous occlusion of blood vessels if the protective mechanisms of coagulation factor inhibitors, blood
More informationCorrelation between Low Folate Levels and Hyperhomocysteinemia, but not with Vitamin B12 in Hypertensive Patients
286 Available online at www.annclinlabsci.org Correlation between Low Folate Levels and Hyperhomocysteinemia, but not with Vitamin B12 in Hypertensive Patients C. Scazzone 1, A. Bono 1, F. Tornese 2, R.
More informationResearch Article. Effect of folic acid on serum homocysteine levels in patients with cardiovascular diseases (CVD)
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2014, 6(3):1141-1148 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Effect of folic acid on serum homocysteine levels
More informationMetabolic Dr Elizabeth Mumper
MINDD Forum General Session Metabolic Elizabeth Mumper, MD Director of Medical Education Autism Research Institute May 2009 Vicious Cycles Food sensitivities Gut inflammation Malabsorption oxidative stress
More informationCardioGenomicPlus Profile
CardioGenomicPlus Profile Patient: SAMPLE PATIENT DOB: Sex: MRN: Apo E Chromosome 19 APOE APO E2: cys / cys APO E3: cys / arg APO E4: arg / arg The two SNPs lead to 3 possible variants for each chromosome,
More informationInternational Journal of Current Research in Medical Sciences
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 www.ijcrims.com Coden: IJCRPP(USA) Research Article http://s-o-i.org/1.15/ijcrms-2016-2-1-5 How Raised Homocysteine is Correlated
More informationHomocysteine and thiol metabolites in vitamin B 12 deficiency
Clinical Science (2001) 100, 111 116 (Printed in Great Britain) 111 Homocysteine and thiol metabolites in vitamin B 12 deficiency L. R. RANGANATH*, M. BAINES and N. B. ROBERTS *Department of Chemical Pathology,
More informationElevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction
Bangladesh Med Res Counc Bull 2012; 38: 9-13 Elevated serum homocysteine level has a positive correlation with serum cardiac troponin I in patients with acute myocardial infarction Abstract Alam N, Khan
More informationGeneral introduction
1 General introduction Essentials of homocysteine and 1-carbon metabolism Cardiovascular disease (CVD) is one of the most prominent causes of death in the modern world. Research has shown that a combination
More informationAmin Aboali Hassan. Department Of Ophthalmology, Sohag University Hospital, Faculty of Medicine, Sohag University, Egypt
Three -Year Incidence and Risk Factors for Retinal Vein Occlusion in Sohag University Hospital Amin Aboali Hassan Department Of Ophthalmology, Sohag University Hospital, Faculty of Medicine, Sohag University,
More informationSerum Total Homocysteine and Coronary Heart Disease
International Journal of Epidemiology O International Eptctemlotoglcal Association 1995 Vol. 24, No. 4 Printed In Great Britain Serum Total Homocysteine and Coronary Heart Disease EGIL ARNESEN,* HELGA
More informationThe effect of nickel on homocysteine metabolism in patients with end-stage renal disease on hemodialysis and in vitro in peripheral mononuclear cells
SHORT THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) The effect of nickel on homocysteine metabolism in patients with end-stage renal disease on hemodialysis and in vitro in peripheral mononuclear
More informationJoshua A. Beckman, MD. Brigham and Women s Hospital
Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham
More informationCauses of Hyperhomocysteinemia in Patients With Chronic Kidney Diseases
Causes of Hyperhomocysteinemia in Patients With Chronic Kidney Diseases Giacomo Garibotto, Antonella Sofia, Alessandro Valli, Alice Tarroni, Massimiliano Di Martino, Valeria Cappelli, Francesca Aloisi,
More informationHyperhomocysteinaemia in Black patients with cerebral thrombosis
Q J Med 1997; 90:635-639 Hyperhomocysteinaemia in Black patients with cerebral thrombosis R. DELPORT 1, J.B. UBBINK\ W.J.H. VERMAAK 1, H. ROSSOUW 1, P.J. BECKER 2 andj. JOUBERT 3 * From the ^Department
More informationRelationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases
Relationship between serum glutathione peroxidase-1activity with endothelial dysfunction level in patients with coronary artery diseases Introduction Reactive oxygen species (ROS),such as superoxide and
More informationUCLA Nutrition Noteworthy
UCLA Nutrition Noteworthy Title Vitamin C and the Risk of Coronary Heart Disease Permalink https://escholarship.org/uc/item/5xg9t04z Journal Nutrition Noteworthy, 4(1) ISSN 1556-1895 Author Chang, Angela
More informationEVERYDAY CLINICAL APPLICATION OF TELOMERE AND AGING SUPPORT PRESENTED BY: Fred Pescatore, MD, MPH, CCN
EVERYDAY CLINICAL APPLICATION OF TELOMERE AND AGING SUPPORT PRESENTED BY: Fred Pescatore, MD, MPH, CCN Financial Disclosure: Consultant to DaVinci Labs AGENDA Overview of the following: Methylation Telomere
More informationThe Effects of Hyperhomocysteinemia on the Presence, Extent, and Severity of Coronary Artery Disease
The Effects of Hyperhomocysteinemia on the Presence, Extent, and Severity of Coronary Artery Disease Abdi BOZKURT, 1 MD, Hale TOYAKSI, 2 MD, Esmeray ACARTÜRK, 1 MD, Abdullah TULI, 2 MD, and Murat ÇAYLI,
More informationDiabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?
Retinopathy Diabetes has a negative effect on eyes in many ways, increasing the risk of cataracts for example, but the most common and serious ocular complication of diabetes is retinopathy. Diabetic retinopathy
More informationKey words: Risk factor. Hyperhomocysteinemia. Ischemic heart disease. Smoking.
j c p s p September 2004 Volume 14 Number 09 September 2004 Home JCPSP Home Sep JCPSP Contents Email JCPSP HYPERHOMOCYSTEINEMIA AS A RISK FACTOR FOR ISCHEMIC HEART DISEASE Muhammad Aamir, Abdus Sattar,*
More informationISSN: Asian Journal of Medical and Pharmaceutical Researches Asian J. Med. Pharm. Res. 4(2): , 2014
\\\\ Received 12 Apri. 2014 Accepted 25 May. 2014 ORIGINAL ARTICLE 2014 Scienceline Publication www.science-line.com ISSN: 2322-4789 Asian Journal of Medical and Pharmaceutical Researches Asian J. Med.
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationAMINO ACID METABOLISM
AMINO ACID METABOLISM Synthesis of Urea in Liver The series of reactions that form urea is known as the Urea Cycle or the Krebs-Henseleit Cycle. The urea cycle operates only to eliminate excess nitrogen.
More informationClinical Importance of MTHFR Gene Polymorphism in Coronary Artery Disease: A Study from India
Human Journals Research Article September 2018 Vol.:13, Issue:2 All rights are reserved by Alpana Saxena et al. Clinical Importance of MTHFR Gene Polymorphism in Coronary Artery Disease: A Study from India
More informationMeeting folate and related B-vitamin requirements through food: Is it enough? Role of fortification and dietary supplements
Meeting folate and related B-vitamin requirements through food: Is it enough? Role of fortification and dietary supplements Helene McNulty PhD RD Northern Ireland Centre for Food and Health (NICHE) University
More informationImpaired Homocysteine Metabolism and Atherothrombotic Disease. Philippe Durand, Michel Prost, Nadine Loreau, Suzanne Lussier-Cacan, and Denis Blache
0023-6837/01/8105-645$03.00/0 LABORATORY INVESTIGATION Vol. 81, No. 5, p. 645, 2001 Copyright 2001 by The United States and Canadian Academy of Pathology, Inc. Printed in U.S.A. MINIREVIEW Impaired Homocysteine
More informationClinical Study Evaluation of Peripapillary Nerve Fiber Layer after Dexamethasone Implantation (Ozurdex) in Branch Retinal Vein Occlusions
Ophthalmology Volume 2016, Article ID 2050796, 4 pages http://dx.doi.org/10.1155/2016/2050796 Clinical Study Evaluation of Peripapillary Nerve Fiber Layer after Dexamethasone Implantation (Ozurdex) in
More informationWhy Use Genetic Testing in Practice?
Pure Encapsulations is committed to producing the most complete line of research-based nutritional supplements. Available through health professionals, finished products are pure and hypoallergenic to
More informationMethylene Tetrahydrofolate Reductase Gene and Coronary Artery Disease
Methylene Tetrahydrofolate Reductase Gene and Coronary Artery Disease M. P. Iqbal,P. M. Frossard ( Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi. ) Hyperhomocysteinemia
More informationMTHFR gene polymorphism, homocysteine and cardiovascular disease
Public Health Nutrition: 4(2B), 493±497 DOI: 10.1079/PHN2001159 MTHFR gene polymorphism, homocysteine and cardiovascular disease Claudio Cortese 1 * and Corradino Motti 2 1 Department of Internal Medicine,
More informationAdvanced Methylation Detoxification Profile
Page: 1 of 6 Pages Methylation Detoxification Cycle: One or more mutations present: Enzyme activity will be mildly to moderately reduced (see detailed report)* No mutations present: Normal enzyme activity*
More informationCase Follow Up. Sepi Jooniani PGY-1
Case Follow Up Sepi Jooniani PGY-1 Triage 54 year old M Pt presents to prelim states noticed today he had reddness to eyes, states worse in R eye. Pt denies any pain or itching. No further complaints.
More informationIs Homocysteine Making You Sick? A New Bioactive Form of Folic Acid Can Lower Stubbornly High Homocysteine Levels When Ordinary B- Vitamins Fail
http://www.lef.org/ Life Extension Magazine August 2009 Is Homocysteine Making You Sick? A New Bioactive Form of Folic Acid Can Lower Stubbornly High Homocysteine Levels When Ordinary B- Vitamins Fail
More informationLaboratory Evaluation of Venous Thrombosis Risk
Laboratory Evaluation of Venous Thrombosis Risk Dorothy M. Adcock, MD Volume 17, Number 12 December 2003 Objective: The reader will be able to discuss the concepts of risk factor, risk potential and thrombotic
More information! These tests are not 100% accurate! Positive findings indicates predisposition only.! Results should not be interpreted as diagnostic with treatment
INTERPRETATION ! These tests are not 100% accurate! Positive findings indicates predisposition only.! Results should not be interpreted as diagnostic with treatment recommendations. ! Normal gene (-)
More informationResearch Article http://www.alliedacademies.org/clinical-ophthalmology-and-vision-science/ A 2-year retrospective study of the treatment of retinal vein occlusion with dexamethasone 0.7 mg intravitreal
More informationHomocysteine enzymatic assay A strong, independent risk factor for cardiovascular disease
References 1 World Health rganization. Fact sheet No. 317. Cardiovascular diseases (CVDs). Available at: www.who.int/mediacentre/factsheets/fs317/en/index.html [Accessed ctober 19, 2012]. 2 World Health
More informationNew vessel formation in retinal branch vein occlusion
Brit. 7. Ophthal. (I 976) 6o, 8io New vessel formation in retinal branch vein occlusion JOHN S. SHILLING AND EVA M. KOHNER From the Retinal Diagnostic Unit, Moorfields Eye Hospital, London Neovascularization
More informationHomocysteine levels and cardiovascular disease in migraine with aura
J Headache Pain (2003) 4:62 66 DOI 10.1007/s10194-003-0032-y ORIGINAL Eleonora Ferraris Nadia Marzocchi Daria Brovia Carmela N. Castellana Luigi A. Pini Homocysteine levels and cardiovascular disease in
More informationHomocystinuria: what about mild
Postgrad Med J 1996; 72: 513-518 ( The Fellowship of Postgraduate Medicine, 1996 Classic diseases revisited Summary Hyperhomocysteinaemia is associated with an increased risk of atherosclerotic vascular
More informationHomocysteine is an amino acid produced as an intermediate
CLINICAL REVIEW Homocysteine and Vascular Disease Christopher A. Friedrich, MD, PhD, and Daniel J. Rader, MD Homocysteine is an amino acid produced as an intermediate product in the metabolism of methionine,
More informationGlucose-6-Phosphate Dehydrogenase Deficiency and Diabetes Mellitus with Severe Retinal Complications in a Sardinian Population, Italy
Research Paper Ivyspring International Publisher 1907 International Journal of Medical Sciences 2013; 10(13):1907-1913. doi: 10.7150/ijms.6776 Glucose-6-Phosphate Dehydrogenase Deficiency and Diabetes
More informationHomocysteine (Hcy) is a non-essential, thiol containing, amino acid. It is
Abstract Homocysteine (Hcy) is a non-essential, thiol containing, amino acid. It is produced in the body as an intermediate during the break down of methionine. Hcy has been associated with several diseases
More informationP H Whincup, H Refsum, I J Perry, R Morris, M Walker, L Lennon, A Thomson, P M Ueland, S B J Ebrahim
448 Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, London NW3 2PF, UK P H Whincup R Morris M Walker L Lennon A Thomson S B J Ebrahim
More information9 Metabolic trigger: control of methionine metabolism
9 Metabolic trigger: control of methionine metabolism M.V. Martinov 1,V.M.Vitvitsky 1,E.V.Mosharov 2,R.Banerjee 2,F.I.Ataullakhanov 1 1 National Research Center for Hematology, Moscow, Russia 125167 2
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Multivariate Analysis of Intravitreal Injection of Anti-VEGF Bevacizumab in the Treatment
More informationVDR GENE (Vitamin D Receptor)
12 GENES EXPLAINED. VDR GENE (Vitamin D Receptor) What is the purpose of the VDR gene? The Vitamin D receptor gene influences the ability to efficiently use vitamin D. Healthy bone density and strength
More informationAssociation of Homocysteine Levels With Blood Lead Levels and Micronutrients in the US General Population
Original Article J Prev Med Public Health 202;45:387-393 http://dx.doi.org/0.396/jpmph.202.45.6.387 pissn 975-8375 eissn 2233-452 Journal of Preventive Medicine & Public Health Association of Homocysteine
More informationand Folic Acid in Type II Diabetes Mellitus Patients.
Research Article ISSN: 974-6943 M. Prabhuet al. / Journal of Pharmacy Research 214,8(1),1398-145 Available online through http://jprsolutions.info Investigation of the Effect of on the Level of Plasma
More informationRetinal Vein Occlusion (RVO) Treatment pathway- Northeast England. Retinal Vein Occlusion (RVO) with Macular oedema (MO)
Retinal Vein Occlusion (RVO) Treatment pathway- Northeast England (Royal Victoria Infirmary, Sunderland Eye Infirmary, James Cook University Hospital, Darlington Memorial Hospital, University Hospital
More informationNon-commercial use only
Familial hyperhomocysteinemia, age and peripheral vascular diseases - an Italian study Sandro Michelini, 1 Marco Cardone, 1 Adriano Micci, 1 Francesco Cappellino, 1 Alessandro Fiorentino, 1 Vincenzo Sainato,
More informationLipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation
Patient: SAMPLE PATIENT DOB: Sex: MRN: 3701 CV Health Plus Genomics - Plasma, Serum & Buccal Swab Methodology: Chemiluminescent, Enzymatic, Immunoturbidimetric, NMR and PCR Lipid Markers Cholesterol LDL-
More informationAssociation of Retinal Vessel Caliber to Optic Disc and Cup Diameters. Kristine E. Lee, Barbara Eden Kobrin Klein, Ronald Klein, and Stacy M.
Association of Retinal Vessel Caliber to Optic Disc and Cup Diameters Kristine E. Lee, Barbara Eden Kobrin Klein, Ronald Klein, and Stacy M. Meuer PURPOSE. To investigate whether optic disc size is related
More informationThe Effect of Physical Activity on Blood Homocysteine Concentration
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 9 (2017) pp. 1206-1210 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.609.146
More information